Kaye Jack

Director at QURE; Director at KERYX BIOPHARMACEUTICALS INC

Sold, on record
$3.2M
Dollars the filings state
Form 4 sales
17
Latest Jun 30, 2026
Form 144 notices
6
Proposed sales
Quarters with a sale
4 of the last 8
7 days with a sale in that time
Companies
2
Filed as an executive or holder

Companies

Sales by reason

3
Routine
8
Plan not stated
3
No plan
3
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Jun 30, 2026Unusual

    QURE

    Sold 44.9% of their holdings

    $983k21,167 shares at $46.44

    Filed Jul 2, 2026Form 4

  2. Jun 30, 2026Notice

    QURE

    Filed a notice to sell 21,167 shares

    $983k21,167 shares

    Filed Jun 30, 2026Form 144

  3. Jun 17, 2026Routine

    QURE

    Sold 16.9% of their holdings

    $225k5,295 shares at $42.57

    Filed Jun 22, 2026Form 4

  4. Jun 17, 2026Notice

    QURE

    Filed a notice to sell 5,295 shares

    $225k5,295 shares

    Filed Jun 17, 2026Form 144

  5. Jun 11, 2026No plan

    QURE

    Sold 7.1% of their holdings

    $54k1,993 shares at $27.06

    Filed Jun 12, 2026Form 4

  6. Jun 11, 2026Notice

    QURE

    Filed a notice to sell 1,993 shares

    $54k1,993 shares

    Filed Jun 11, 2026Form 144

  7. Jun 3, 2026Routine

    QURE

    Sold 11.5% of their holdings

    $79k2,645 shares at $30.01

    Filed Jun 5, 2026Form 4

  8. Jun 3, 2026Notice

    QURE

    Filed a notice to sell 2,645 shares

    $79k2,645 shares

    Filed Jun 3, 2026Form 144

  9. Jan 9, 2026Routine

    QURE

    Sold 23.8% of their holdings

    $174k6,390 shares at $27.28

    Filed Jan 12, 2026Form 4

  10. Jan 9, 2026Notice

    QURE

    Filed a notice to sell 6,390 shares

    $174k6,390 shares

    Filed Jan 9, 2026Form 144

10 of 23

Every transaction

Every transaction on a Form 4 or Form 5 by Kaye Jack
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jun 30, 2026Jul 2, 2026QUREDirectorSold21,167$46.44$983k25,996SEC
Jun 30, 2026Jul 2, 2026QUREDirectorExercised or settledStock Option (Right to Buy)21,1670SEC
Jun 30, 2026Jul 2, 2026QUREDirectorExercised options21,167$23.44$496k43,056SEC
Jun 17, 2026Jun 22, 2026QUREDirectorSold5,295$42.57$225k25,996SEC
Jun 17, 2026Jun 22, 2026QUREDirectorExercised or settledStock Option (Right to Buy)5,2950SEC
Jun 17, 2026Jun 22, 2026QUREDirectorExercised options5,295$31.71$168k31,291SEC
Jun 11, 2026Jun 12, 2026QUREDirectorSold1,993$27.06$54k25,996SEC
Jun 10, 2026Jun 12, 2026QUREDirectorAwardedStock Option (Right to Buy)13,98013,980SEC
Jun 10, 2026Jun 12, 2026QUREDirectorAwarded7,55027,989SEC
Jun 3, 2026Jun 5, 2026QUREDirectorSold2,645$30.01$79k20,439SEC
Jun 3, 2026Jun 5, 2026QUREDirectorExercised or settledStock Option (Right to Buy)2,6450SEC
Jun 3, 2026Jun 5, 2026QUREDirectorExercised options2,645$16.04$42k23,084SEC
Jan 9, 2026Jan 12, 2026QUREDirectorSold6,390$27.28$174k20,439SEC
Jan 9, 2026Jan 12, 2026QUREDirectorExercised or settledStock Option (Right to Buy)6,3900SEC
Jan 9, 2026Jan 12, 2026QUREDirectorExercised options6,390$19.39$124k26,829SEC
Jan 2, 2026Jan 6, 2026DYAIDirectorExercised or settledRestricted Stock Unit21,5520SEC
Jan 2, 2026Jan 6, 2026DYAIDirectorExercised options21,55281,201SEC
Jan 2, 2026Jan 6, 2026DYAIDirectorAwardedStock Option107,39439,894SEC
Nov 4, 2025Nov 6, 2025QUREDirectorSold38,810$30.34$1.2M20,439SEC
Nov 4, 2025Nov 6, 2025QUREDirectorExercised or settledStock Option (Right to Buy)38,8100SEC
Nov 4, 2025Nov 6, 2025QUREDirectorExercised options38,810$9.88$384k38,249SEC
Jun 20, 2025Jun 24, 2025QUREDirectorSold2,112$14.45$31k20,439SEC
Jun 11, 2025Jun 13, 2025QUREDirectorAwardedStock Option (Right to Buy)15,63015,630SEC
Jun 11, 2025Jun 13, 2025QUREDirectorAwarded7,97022,551SEC
Mar 5, 2025Mar 7, 2025DYAIDirectorExercised or settledStock Option30,0000SEC
Mar 5, 2025Mar 7, 2025DYAIDirectorExercised options30,000$1.33$40k87,166SEC
Mar 5, 2025Mar 7, 2025DYAIDirectorWithheld for tax27,517$1.45$40k59,649SEC
Jan 2, 2025Jan 7, 2025DYAIDirectorExercised or settledRestricted Stock Unit23,5850SEC
Jan 2, 2025Jan 7, 2025DYAIDirectorExercised options23,58557,166SEC
Jan 2, 2025Jan 7, 2025DYAIDirectorAwardedStock Option89,05221,552SEC
Jun 19, 2024Jun 21, 2024QUREDirectorAwardedStock Option (Right to Buy)15,84015,840SEC
Jun 19, 2024Jun 21, 2024QUREDirectorAwarded8,08014,581SEC
Jun 13, 2024Jun 17, 2024QUREDirectorSold2,218$5.16$11k6,501SEC
Jan 3, 2024Jan 4, 2024DYAIDirectorExercised or settledRestricted Stock Unit27,1740SEC
Jan 3, 2024Jan 4, 2024DYAIDirectorExercised options27,17433,581SEC
Jan 2, 2024Jan 4, 2024DYAIDirectorAwardedStock Option91,08523,585SEC
Jun 23, 2023Feb 6, 2024QUREDirectorGift25,4008,719SEC
Jun 16, 2023Jun 20, 2023QUREDirectorSold2,280$18.93$43k34,119SEC
Jun 13, 2023Jun 20, 2023QUREDirectorAwardedStock Option (Right to Buy)17,06017,060SEC
Jun 13, 2023Jun 20, 2023QUREDirectorAwarded8,70036,399SEC
Feb 27, 2023Mar 1, 2023QUREDirectorSold384$19.99$8k27,699SEC
Jan 3, 2023Jan 5, 2023DYAIDirectorAwardedStock Option79,67427,174SEC
Nov 21, 2022Jan 5, 2023DYAIDirectorGift66,3006,407SEC
Jun 15, 2022Jun 17, 2022QUREDirectorAwardedStock Option (Right to Buy)17,81017,810SEC
Jun 15, 2022Jun 17, 2022QUREDirectorAwarded9,08028,083SEC
Jun 10, 2022Jun 14, 2022DYAIDirectorAwardedStock Option25,00025,000SEC
Feb 28, 2022Mar 2, 2022QUREDirectorSold600$16.76$10k19,003SEC
Feb 24, 2022Feb 28, 2022QUREDirectorAwardedStock Option (Right to Buy)2,6452,645SEC
Feb 24, 2022Feb 28, 2022QUREDirectorAwarded1,53419,603SEC
Jan 3, 2022Jan 5, 2022DYAIDirectorAwardedStock Option52,50052,500SEC
Page 1

Sales and notices (23)

Form 144 notices and Form 4 sales by Kaye Jack
Source
Jun 30, 2026Jul 2, 2026QUREDirectorForm 4 sale21,167$983k44.9%UnusualSEC
Jun 30, 2026Jun 30, 2026QUREDirectorForm 144 notice21,167$983kNoticeSEC
Jun 17, 2026Jun 22, 2026QUREDirectorForm 4 sale5,295$225k16.9%RoutineSEC
Jun 17, 2026Jun 17, 2026QUREDirectorForm 144 notice5,295$225kNoticeSEC
Jun 11, 2026Jun 12, 2026QUREDirectorForm 4 sale1,993$54k7.1%No planSEC
Jun 11, 2026Jun 11, 2026QUREDirectorForm 144 notice1,993$54kNoticeSEC
Jun 3, 2026Jun 5, 2026QUREDirectorForm 4 sale2,645$79k11.5%RoutineSEC
Jun 3, 2026Jun 3, 2026QUREDirectorForm 144 notice2,645$79kNoticeSEC
Jan 9, 2026Jan 12, 2026QUREDirectorForm 4 sale6,390$174k23.8%RoutineSEC
Jan 9, 2026Jan 9, 2026QUREDirectorForm 144 notice6,390$174kNoticeSEC
Nov 4, 2025Nov 6, 2025QUREDirectorForm 4 sale38,810$1.2M65.5%UnusualSEC
Nov 4, 2025Nov 4, 2025QUREDirectorForm 144 notice38,810$1.3MNoticeSEC
Jun 20, 2025Jun 24, 2025QUREDirectorForm 4 sale2,112$31k9.4%No planSEC
Jun 13, 2024Jun 17, 2024QUREDirectorForm 4 sale2,218$11k25.4%UnusualSEC
Jun 16, 2023Jun 20, 2023QUREDirectorForm 4 sale2,280$43k6.3%No planSEC
Feb 27, 2023Mar 1, 2023QUREDirectorForm 4 sale384$8k1.4%Plan not statedSEC
Feb 28, 2022Mar 2, 2022QUREDirectorForm 4 sale600$10k3.1%Plan not statedSEC
Mar 2, 2021Mar 4, 2021QUREDirectorForm 4 sale504$19k2.7%Plan not statedSEC
Jan 28, 2020Jan 30, 2020QUREDirectorForm 4 sale806$50k5.4%Plan not statedSEC
Jan 28, 2019Jan 31, 2019QUREDirectorForm 4 sale1,210$38k7.5%Plan not statedSEC
Jan 29, 2018Jan 31, 2018QUREDirectorForm 4 sale2,878$53k18.2%Plan not statedSEC
Dec 6, 2010Dec 8, 2010KERYX BIOPHARMACEUTICALS INCDirectorForm 4 sale20,000$100k12.4%Plan not statedSEC
Sep 29, 2010Oct 1, 2010KERYX BIOPHARMACEUTICALS INCDirectorForm 4 sale25,000$125k13.4%Plan not statedSEC